Breaking News Instant updates and real-time market news.

ALLO

Allogene Therapeutics

$28.89

0.11 (0.38%)

05:42
11/04/19
11/04
05:42
11/04/19
05:42

Allogene Therapeutics initiated with a Buy at Canaccord

Canaccord analyst John Newman initiated coverage of Allogene Therapeutics with a Buy rating and $36 price target.

  • 05

    Nov

  • 07

    Dec

ALLO Allogene Therapeutics
$28.89

0.11 (0.38%)

05/30/19
05/30/19
INITIATION
Target $25

Buy
Rubius Therapeutics, Fate Therapeutics initiated with a Buy at Guggenheim
As previously reported, Guggenheim analyst Michael Schmidt initiated Rubius Therapeutics (RUBI) and Fate Therapeutics (FATE) with a Buy rating and Allogene Therapeutics (ALLO) with a Neutral rating as part of a broader research note of 3 biotechnology stocks that developed "innovative" next-gen cell therapy platforms. The analyst has a $25 price target on Fate Therapeutics, saying the company could "leapfrog" competitors by applying its induced pluripotent stem cell, or iPSC, platform toward "engineered off-the-shelf cancer immunotherapies in a dish". While still at an early stage, Schmidt says the platform may improve upon its initial shortcomings in first and also second generation cellular cancer immunotherapies toward a broad set of therapeutic areas. The analyst is also positive on the "unique red cell therapeutics platform" of Rubius Therapeutics and its upcoming proof-of-concept data in the second half of this year, with an "extremely broad" range of potential applications including rare genetic diseases to cancer and autoimmune diseases. Schmidt also assigns $25 price target to Rubius. For Allogene Therapeutics, Schmidt says he is positive on its potential front-runner status in bringing off-the-shelf CAR-T to market, but sees much of its potential having been priced into the stock.
06/05/19
ROTH
06/05/19
INITIATION
Target $26
ROTH
Neutral
Allogene Therapeutics initiated with a Neutral at Roth Capital
Roth Capital analyst Tony Butler started Allogene Therapeutics with a Neutral rating and $26 price target. Allogene has a "strong team, a strong platform, and access to significant resources to continue development efforts," Butler tells investors in a research note. However, he believes the market has "somewhat priced" these into the stock at current levels.
08/09/19
BTIG
08/09/19
INITIATION
BTIG
Buy
Allogene Therapeutics initiated with a Buy at BTIG
08/09/19
BTIG
08/09/19
INITIATION
Target $37
BTIG
Buy
Allogene Therapeutics initiated with a Buy at BTIG
BTIG analyst Amanda Murphy initiated Allogene Therapeutics with a Buy rating and a price target of $37 as part of her broader research note on CAR-T cell therapy names developing "off-the-shelf" engineered cell therapeutics for oncology. The analyst notes the company is "well capitalized" with $650M in cash and equivalents with the upcoming catalysts that include the "advancement of UCART19 to potential registrational trials expected in 2020 and the presentation of initial data from the Phase 1 portion of the ongoing ALPHA trial."

TODAY'S FREE FLY STORIES

FMCC

Freddie Mac

$0.00

(0.00%)

21:42
12/05/19
12/05
21:42
12/05/19
21:42
Initiation
Freddie Mac initiated  »

Freddie Mac initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$47.16

1.88 (4.15%)

21:00
12/05/19
12/05
21:00
12/05/19
21:00
Syndicate
GDS Holdings 5.49M share Secondary priced at $45.50 »

JPMorgan, RBC Capital and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 06

    Dec

BIG

Big Lots

$19.17

-0.75 (-3.77%)

, GCO

Genesco

$36.94

0.38 (1.04%)

20:25
12/05/19
12/05
20:25
12/05/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BIG

Big Lots

$19.17

-0.75 (-3.77%)

GCO

Genesco

$36.94

0.38 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

UNVR

Univar

$23.15

0.22 (0.96%)

20:10
12/05/19
12/05
20:10
12/05/19
20:10
Hot Stocks
Univar to sell environmental sciences business to AEA Investors for $195M »

Univar announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLUG

Plug Power

$3.10

-0.195 (-5.93%)

20:04
12/05/19
12/05
20:04
12/05/19
20:04
Syndicate
Plug Power 40M share Secondary priced at $2.75 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

RGLD

Royal Gold

$117.91

0.64 (0.55%)

, TECK

Teck Resources

$15.71

-0.11 (-0.70%)

20:03
12/05/19
12/05
20:03
12/05/19
20:03
Hot Stocks
Royal Gold updates on Andacollo Workers Union ratifying 36-month collective deal »

Royal Gold (RGLD)…

RGLD

Royal Gold

$117.91

0.64 (0.55%)

TECK

Teck Resources

$15.71

-0.11 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IR

Ingersoll-Rand

$128.95

1.405 (1.10%)

19:41
12/05/19
12/05
19:41
12/05/19
19:41
Upgrade
Ingersoll-Rand rating change at Wells Fargo »

Ingersoll-Rand upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$119.86

2.42 (2.06%)

19:06
12/05/19
12/05
19:06
12/05/19
19:06
Hot Stocks
Intercept Phase 3 study for OCA in fibrosis patients published in The Lancet »

Intercept announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

HUN

Huntsman

$22.34

0.37 (1.68%)

18:52
12/05/19
12/05
18:52
12/05/19
18:52
Hot Stocks
Huntsman acquires Icynene-Lapolla for all-cash payment of $350M »

Huntsman announces its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 18

    Dec

  • 19

    Dec

UBER

Uber

$28.65

-0.405 (-1.39%)

18:48
12/05/19
12/05
18:48
12/05/19
18:48
Hot Stocks
Uber: Non-consensual kissing of sexual body part reported in 1 in 3M U.S. trips »

Uber released its Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$28.65

-0.405 (-1.39%)

18:45
12/05/19
12/05
18:45
12/05/19
18:45
Hot Stocks
Uber says fatal physical assault reported in 1 in every 122M U.S. trips »

Uber released its Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOMO

Domo

$19.47

-0.19 (-0.97%)

, EZPW

Ezcorp

$5.21

-0.01 (-0.19%)

18:44
12/05/19
12/05
18:44
12/05/19
18:44
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Domo…

DOMO

Domo

$19.47

-0.19 (-0.97%)

EZPW

Ezcorp

$5.21

-0.01 (-0.19%)

DOCU

DocuSign

$69.51

-0.465 (-0.66%)

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

CLDR

Cloudera

$10.02

0.16 (1.62%)

MDLA

Medallia

$29.79

0.55 (1.88%)

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

AOBC

American Outdoor Brands

$9.42

0.38 (4.20%)

YEXT

Yext

$16.62

0.065 (0.39%)

PD

PagerDuty

$24.99

-0.66 (-2.57%)

SAIC

SAIC

$83.82

-0.57 (-0.68%)

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

KFY

Korn/Ferry

$40.26

0.39 (0.98%)

COO

Cooper Companies

$313.10

1 (0.32%)

GWRE

Guidewire

$119.32

0.68 (0.57%)

OKTA

Okta

$119.18

-2.64 (-2.17%)

UBER

Uber

$28.65

-0.405 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 16

    Dec

  • 17

    Dec

  • 17

    Dec

UBER

Uber

$28.65

-0.405 (-1.39%)

18:43
12/05/19
12/05
18:43
12/05/19
18:43
Hot Stocks
Uber says 107 total fatalities in 2017-2018 reported in relation to Uber app »

Uber released its Safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$28.65

-0.405 (-1.39%)

18:34
12/05/19
12/05
18:34
12/05/19
18:34
Periodicals
Breaking Periodicals news story on Uber »

Uber reports 3,000 sexual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$819.61

10.12 (1.25%)

18:33
12/05/19
12/05
18:33
12/05/19
18:33
Hot Stocks
Chipotle CEO: I took time to understand what makes us unique »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$26.02

0.36 (1.40%)

18:17
12/05/19
12/05
18:17
12/05/19
18:17
Hot Stocks
Rent-A-Center raises quarterly dividend to 29c from 25c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$76.66

0.01 (0.01%)

18:02
12/05/19
12/05
18:02
12/05/19
18:02
Hot Stocks
Black Hills utilities receive approval to upsize Renewable Ready program »

Black Hills announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRIM

Primoris

$21.92

0.3 (1.39%)

18:02
12/05/19
12/05
18:02
12/05/19
18:02
Hot Stocks
Primoris awarded two pipeline contracts for over $45M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMAT

LeMaitre

$35.94

-0.09 (-0.25%)

18:01
12/05/19
12/05
18:01
12/05/19
18:01
Hot Stocks
LeMaitre CFO sells 121K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLBK

Columbia Financial

$16.33

-0.24 (-1.45%)

18:01
12/05/19
12/05
18:01
12/05/19
18:01
Hot Stocks
Columbia Financial expands stock buyback to acquire additional 3M shares »

Columbia Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXS

Axis Capital

$58.42

0.31 (0.53%)

17:49
12/05/19
12/05
17:49
12/05/19
17:49
Hot Stocks
Axis Capital increases quarterly dividend 2.5% to 41c per share »

Axis Capital has declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PZZA

Papa John's

$59.67

-0.53 (-0.88%)

17:48
12/05/19
12/05
17:48
12/05/19
17:48
Periodicals
Former Papa John's CEO files suit against ad firm, Bloomberg says »

Papa John's founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

THG

Hanover Insurance

$133.80

0.52 (0.39%)

17:47
12/05/19
12/05
17:47
12/05/19
17:47
Hot Stocks
Hanover Insurance raises dividend to 65c/shr, announces $2.50 special dividend »

The Hanover Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

BHVN

Biohaven Pharmaceutical

$53.79

-0.235 (-0.44%)

17:46
12/05/19
12/05
17:46
12/05/19
17:46
Hot Stocks
Biohaven Pharmaceutical issued patent relating to troriluzole »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

17:45
12/05/19
12/05
17:45
12/05/19
17:45
Upgrade
Morgan Stanley upgrades Epizyme to Overweight ahead of lymphoma data »

Morgan Stanley analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.